get started quickly with…
manage accounts
business insights
download guides
how to grow your business online – videos help
Cuisque cursus metus vitae sedpharetra auctor interdum magna auge get diam mas vestibulum anipsum faucibus ipsum.
how to easily generate successful business ideas
business registration platforms for a streamlined process
frequently asked questions
No, SPRAVATO® must be administered in a certified healthcare setting.
The cost of SPRAVATO® depends on your insurance plan.
SPRAVATO® should be administered in conjunction with an oral antidepressant (AD).
SPRAVATO® (esketamine) CIII nasal spray is the S-enantiomer of racemic ketamine. SPRAVATO® is an FDA-approved nasal spray for TRD and MDSI. Ketamine infusion has not been approved by the FDA to treat depression. There are no head-to-head studies comparing esketamine and ketamine infusion. Both SPRAVATO® and ketamine are Schedule III controlled substances under the U.S. Controlled Substances Act.
SPRAVATO® (esketamine) CIII nasal spray is the S-enantiomer of racemic ketamine. SPRAVATO® is an FDA-approved nasal spray for TRD and MDSI. Ketamine infusion has not been approved by the FDA to treat depression. There are no head-to-head studies comparing esketamine and ketamine infusion. Both SPRAVATO® and ketamine are Schedule III controlled substances under the U.S. Controlled Substances Act.
SPRAVATO® should be administered in conjunction with an oral antidepressant (AD).
The cost of SPRAVATO® depends on your insurance plan.
No, SPRAVATO® must be administered in a certified healthcare setting.